Literature DB >> 24894656

The effect of the setting of a positive surgical margin in soft tissue sarcoma.

Patrick W O'Donnell1, Anthony M Griffin, William C Eward, Amir Sternheim, Charles N Catton, Peter W Chung, Brian O'Sullivan, Peter C Ferguson, Jay S Wunder.   

Abstract

BACKGROUND: The objectives of this study were to evaluate the risk of local recurrence and survival after soft tissue sarcoma (STS) resection with positive margins and to evaluate the safety of sparing adjacent critical structures.
METHODS: One hundred sixty-nine patients with localized STS who had positive resection margins were identified from a prospective database. Patients who had positive margins were stratified into 3 groups, each representing a specific clinical scenario: critical structure positive margin (eg major nerve, vessel, or bone), tumor bed resection positive margin, and unexpected positive margin. The rates of local recurrence-free survival (LRFS) and cause-specific survival (CSS) were calculated and compared with relevant control patients who had negative margins after STS resection.
RESULTS: After planned close dissection to preserve critical structures, the 5-year LRFS and CSS rates both depended on the quality of the surgical margins (97% and 80.3%, respectively, for those with negative margins vs 85.4% and 59.4%, respectively, for those with positive margins; P = .015 and P = .05, respectively). Negative margins achieved through resection of critical structures because of tumor invasion or encasement only slightly improved the 5-year rates of LRFS (91.2%) and CSS (63.6%; P = .8 and P = .9, respectively). The lowest 5-year LRFS and CSS rates were 63.4% and 59.2%, respectively, after an unexpected positive margin during primary surgery.
CONCLUSIONS: After patients undergo resection of STS with positive margins, oncologic outcomes can be predicted based on the clinical context. Sparing adjacent critical structures in this setting is safe and contributes to improved functional outcomes.
© 2014 American Cancer Society.

Entities:  

Keywords:  morbidity; recurrence; sarcoma; survival

Mesh:

Year:  2014        PMID: 24894656     DOI: 10.1002/cncr.28793

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  41 in total

1.  The accurate surgical margin before surgery for malignant musculoskeletal tumors: a retrospective study.

Authors:  Yun Hao; Caihong Yang; Jinpeng He
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma.

Authors:  Matthew T Houdek; Peter S Rose; Mario Hevesi; Joseph H Schwab; Anthony M Griffin; John H Healey; Ivy A Petersen; Thomas F DeLaney; Peter W Chung; Michael J Yaszemski; Jay S Wunder; Francis J Hornicek; Patrick J Boland; Franklin H Sim; Peter C Ferguson
Journal:  J Surg Oncol       Date:  2019-02-07       Impact factor: 3.454

Review 3.  Extremity Soft Tissue Sarcoma: Role of Local Control.

Authors:  Elyse J Brinkmann; Safia K Ahmed; Matthew T Houdek
Journal:  Curr Treat Options Oncol       Date:  2020-02-05

4.  High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival.

Authors:  Julie Willeumier; Marta Fiocco; Remi Nout; Sander Dijkstra; William Aston; Rob Pollock; Henk Hartgrink; Judith Bovée; Michiel van de Sande
Journal:  Int Orthop       Date:  2015-03-07       Impact factor: 3.075

Review 5.  Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies.

Authors:  Rick L M Haas; Aisha B Miah; Cécile LePechoux; Thomas F DeLaney; Elizabeth H Baldini; Kaled Alektiar; Brian O'Sullivan
Journal:  Radiother Oncol       Date:  2015-12-21       Impact factor: 6.280

6.  Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis.

Authors:  Alicia A Gingrich; Sarah B Bateni; Arta M Monjazeb; Morgan A Darrow; Steven W Thorpe; Amanda R Kirane; Richard J Bold; Robert J Canter
Journal:  Ann Surg Oncol       Date:  2017-07-24       Impact factor: 5.344

Review 7.  Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.

Authors:  Sandro Pasquali; Alessandro Gronchi
Journal:  Ther Adv Med Oncol       Date:  2017-04-16       Impact factor: 8.168

8.  Prognostic Factors in Indian Patients Operated for Soft Tissue Sarcomas-a Retrospective Cross-sectional Analysis.

Authors:  Akshay Tiwari; Swati Shah; Ashwani Kumar Sharma; Sandeep Mehta; Ullas Batra; S K Sharma; A K Dewan
Journal:  Indian J Surg Oncol       Date:  2016-11-02

Review 9.  Preoperative Radiation for Soft Tissue Sarcomas: How Much Is Needed?

Authors:  Safia K Ahmed; Ivy A Petersen
Journal:  Curr Treat Options Oncol       Date:  2022-02-15

10.  Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma.

Authors:  David A J Wilson; Aaron Gazendam; Julia Visgauss; David Perrin; Anthony M Griffin; Peter W Chung; Charles N Catton; David Shultz; Peter C Ferguson; Jay S Wunder
Journal:  Ann Surg Oncol       Date:  2020-03-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.